Boris Draznin
Concepts (590)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Insulin | 97 | 2013 | 2320 | 4.460 |
Why?
| Diabetes Mellitus | 15 | 2021 | 1004 | 3.320 |
Why?
| Hyperglycemia | 10 | 2016 | 326 | 3.240 |
Why?
| Insulin Resistance | 32 | 2013 | 1167 | 2.740 |
Why?
| Phosphatidylinositol 3-Kinases | 17 | 2012 | 357 | 2.210 |
Why?
| Proto-Oncogene Proteins p21(ras) | 23 | 2006 | 259 | 2.110 |
Why?
| Adipocytes | 13 | 2008 | 204 | 1.920 |
Why?
| Receptor, Insulin | 26 | 2003 | 100 | 1.870 |
Why?
| Hypoglycemic Agents | 15 | 2025 | 1217 | 1.750 |
Why?
| Alkyl and Aryl Transferases | 14 | 2003 | 53 | 1.670 |
Why?
| Diabetes Mellitus, Type 2 | 17 | 2025 | 2437 | 1.640 |
Why?
| Blood Glucose | 25 | 2025 | 2096 | 1.630 |
Why?
| Insulin, Long-Acting | 4 | 2020 | 61 | 1.510 |
Why?
| Hyperinsulinism | 11 | 2009 | 119 | 1.320 |
Why?
| Calcium | 21 | 2007 | 1180 | 1.130 |
Why?
| Muscle, Smooth, Vascular | 8 | 2007 | 417 | 1.050 |
Why?
| Protein Prenylation | 11 | 2006 | 34 | 1.040 |
Why?
| Adipose Tissue | 19 | 2007 | 592 | 1.010 |
Why?
| Phosphorylation | 32 | 2013 | 1687 | 0.880 |
Why?
| Signal Transduction | 25 | 2012 | 4838 | 0.850 |
Why?
| Insulin Receptor Substrate Proteins | 15 | 2013 | 60 | 0.850 |
Why?
| Hospitalization | 6 | 2025 | 2077 | 0.840 |
Why?
| Muscle, Skeletal | 11 | 2012 | 1641 | 0.840 |
Why?
| Rats | 69 | 2007 | 5175 | 0.830 |
Why?
| Obesity | 15 | 2013 | 2863 | 0.710 |
Why?
| Cytosol | 16 | 1994 | 214 | 0.700 |
Why?
| Insulin Glargine | 4 | 2014 | 80 | 0.700 |
Why?
| Monosaccharide Transport Proteins | 9 | 2003 | 49 | 0.680 |
Why?
| Glucagon-Like Peptide-1 Receptor | 1 | 2021 | 91 | 0.680 |
Why?
| Epidemics | 1 | 2021 | 83 | 0.660 |
Why?
| Inpatients | 3 | 2013 | 464 | 0.660 |
Why?
| Animals | 106 | 2013 | 34610 | 0.640 |
Why?
| Glucose | 25 | 2006 | 983 | 0.610 |
Why?
| Proteins | 15 | 2001 | 936 | 0.610 |
Why?
| Myocytes, Smooth Muscle | 3 | 2006 | 245 | 0.590 |
Why?
| Physicians, Primary Care | 1 | 2021 | 227 | 0.590 |
Why?
| Enzyme Inhibitors | 13 | 2007 | 811 | 0.580 |
Why?
| Dietary Fats | 5 | 2012 | 301 | 0.570 |
Why?
| Platelet-Derived Growth Factor | 4 | 2003 | 89 | 0.560 |
Why?
| Deoxyglucose | 10 | 2008 | 49 | 0.550 |
Why?
| Endocrinology | 1 | 2018 | 74 | 0.550 |
Why?
| Diabetes Mellitus, Type 1 | 8 | 2020 | 3624 | 0.530 |
Why?
| 3T3-L1 Cells | 5 | 2008 | 34 | 0.520 |
Why?
| Adiponectin | 4 | 2009 | 234 | 0.520 |
Why?
| Enteral Nutrition | 3 | 2013 | 184 | 0.510 |
Why?
| Insulin-Like Growth Factor I | 11 | 2005 | 307 | 0.500 |
Why?
| Medical Staff, Hospital | 1 | 2016 | 79 | 0.500 |
Why?
| Phosphoproteins | 10 | 2007 | 330 | 0.500 |
Why?
| Protein Kinases | 3 | 2008 | 309 | 0.490 |
Why?
| Somatostatin | 13 | 2001 | 54 | 0.480 |
Why?
| Islets of Langerhans | 17 | 1991 | 790 | 0.480 |
Why?
| Academic Medical Centers | 1 | 2018 | 479 | 0.470 |
Why?
| Patient Care Planning | 1 | 2016 | 149 | 0.470 |
Why?
| Farnesyltranstransferase | 11 | 2009 | 35 | 0.470 |
Why?
| Triglycerides | 3 | 2012 | 524 | 0.470 |
Why?
| Insulin, Isophane | 2 | 2013 | 20 | 0.470 |
Why?
| Growth Hormone | 8 | 2007 | 96 | 0.460 |
Why?
| Humans | 67 | 2025 | 129136 | 0.450 |
Why?
| 3T3 Cells | 13 | 2007 | 151 | 0.450 |
Why?
| Dietary Carbohydrates | 3 | 2012 | 152 | 0.450 |
Why?
| Rats, Inbred Strains | 26 | 1992 | 356 | 0.450 |
Why?
| Phosphates | 3 | 2007 | 168 | 0.450 |
Why?
| Cells, Cultured | 25 | 2008 | 4012 | 0.450 |
Why?
| Glucocorticoids | 2 | 2016 | 575 | 0.440 |
Why?
| Guanosine Triphosphate | 12 | 2000 | 92 | 0.420 |
Why?
| Medically Uninsured | 1 | 2014 | 127 | 0.420 |
Why?
| Muscle Proteins | 4 | 2012 | 229 | 0.410 |
Why?
| Kinetics | 24 | 2012 | 1617 | 0.410 |
Why?
| Liver | 15 | 2009 | 1833 | 0.410 |
Why?
| Continuity of Patient Care | 2 | 2019 | 279 | 0.400 |
Why?
| Practice Guidelines as Topic | 2 | 2018 | 1493 | 0.400 |
Why?
| Sirtuin 1 | 1 | 2012 | 30 | 0.390 |
Why?
| Diabetes Mellitus, Experimental | 5 | 1992 | 174 | 0.390 |
Why?
| Biphasic Insulins | 1 | 2011 | 3 | 0.390 |
Why?
| Muscles | 3 | 2004 | 323 | 0.390 |
Why?
| Patient Preference | 1 | 2014 | 186 | 0.390 |
Why?
| Enzyme Activation | 10 | 2008 | 799 | 0.380 |
Why?
| Cystic Fibrosis | 2 | 2012 | 1063 | 0.380 |
Why?
| Sterol Regulatory Element Binding Protein 1 | 3 | 2007 | 57 | 0.380 |
Why?
| Insulin Lispro | 1 | 2011 | 37 | 0.380 |
Why?
| Decision Making | 2 | 2018 | 851 | 0.380 |
Why?
| Cell Membrane | 18 | 2003 | 722 | 0.370 |
Why?
| Patient Care Team | 1 | 2016 | 602 | 0.360 |
Why?
| Mice | 28 | 2009 | 16652 | 0.360 |
Why?
| Patient Admission | 1 | 2012 | 184 | 0.360 |
Why?
| AMP-Activated Protein Kinases | 1 | 2012 | 190 | 0.350 |
Why?
| Methylprednisolone | 1 | 2011 | 82 | 0.350 |
Why?
| Thiazolidinediones | 2 | 2008 | 137 | 0.350 |
Why?
| Hospitals | 2 | 2013 | 632 | 0.340 |
Why?
| Phosphoprotein Phosphatases | 4 | 1995 | 67 | 0.340 |
Why?
| Atherosclerosis | 4 | 2019 | 410 | 0.340 |
Why?
| Blotting, Western | 9 | 2012 | 1169 | 0.340 |
Why?
| Receptors, Cell Surface | 12 | 1986 | 371 | 0.340 |
Why?
| Dose-Response Relationship, Drug | 9 | 2011 | 1945 | 0.340 |
Why?
| Epidermal Growth Factor | 6 | 1998 | 170 | 0.330 |
Why?
| Biomarkers | 3 | 2020 | 3897 | 0.330 |
Why?
| Quality Improvement | 2 | 2018 | 1099 | 0.330 |
Why?
| Pituitary Gland, Anterior | 5 | 1988 | 38 | 0.330 |
Why?
| Phosphoric Monoester Hydrolases | 4 | 1994 | 54 | 0.330 |
Why?
| Male | 55 | 2025 | 63203 | 0.330 |
Why?
| Medicaid | 1 | 2014 | 437 | 0.330 |
Why?
| Adaptor Proteins, Signal Transducing | 5 | 2001 | 391 | 0.330 |
Why?
| Mitogen-Activated Protein Kinase 8 | 1 | 2008 | 15 | 0.310 |
Why?
| rhoA GTP-Binding Protein | 4 | 2003 | 91 | 0.310 |
Why?
| Oligonucleotides, Antisense | 1 | 2009 | 106 | 0.310 |
Why?
| Cyclic AMP Response Element-Binding Protein | 3 | 2001 | 141 | 0.310 |
Why?
| MAP Kinase Signaling System | 3 | 2006 | 303 | 0.310 |
Why?
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2008 | 11 | 0.310 |
Why?
| DNA-Binding Proteins | 5 | 2004 | 1423 | 0.310 |
Why?
| Gene Expression Regulation, Enzymologic | 4 | 2005 | 283 | 0.310 |
Why?
| Cyclic AMP | 9 | 1993 | 230 | 0.300 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinases | 3 | 1997 | 181 | 0.300 |
Why?
| Algorithms | 1 | 2016 | 1621 | 0.300 |
Why?
| Endothelium, Vascular | 2 | 2007 | 872 | 0.300 |
Why?
| Mitochondrial Diseases | 1 | 2008 | 89 | 0.290 |
Why?
| Transfection | 9 | 2008 | 896 | 0.290 |
Why?
| Adult | 19 | 2020 | 35513 | 0.290 |
Why?
| Leukocytes | 2 | 2006 | 303 | 0.280 |
Why?
| Diabetic Angiopathies | 2 | 2007 | 263 | 0.280 |
Why?
| Pregnancy Proteins | 2 | 2005 | 37 | 0.280 |
Why?
| Early Growth Response Protein 1 | 2 | 2006 | 26 | 0.270 |
Why?
| Androstadienes | 5 | 2008 | 107 | 0.270 |
Why?
| Cytoplasmic Granules | 6 | 1986 | 78 | 0.270 |
Why?
| Phosphoserine | 1 | 2006 | 33 | 0.260 |
Why?
| src Homology Domains | 2 | 2003 | 38 | 0.260 |
Why?
| Fetal Macrosomia | 1 | 2006 | 62 | 0.260 |
Why?
| Organophosphonates | 2 | 1997 | 91 | 0.260 |
Why?
| Female | 29 | 2025 | 68519 | 0.260 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 1275 | 0.260 |
Why?
| Glyburide | 6 | 1988 | 35 | 0.260 |
Why?
| Fasting | 7 | 2005 | 264 | 0.260 |
Why?
| Food Deprivation | 1 | 2006 | 21 | 0.260 |
Why?
| Middle Aged | 16 | 2025 | 31080 | 0.250 |
Why?
| Nutritional Physiological Phenomena | 1 | 2006 | 53 | 0.250 |
Why?
| RNA, Messenger | 8 | 2006 | 2676 | 0.250 |
Why?
| Mitogens | 3 | 2001 | 58 | 0.250 |
Why?
| Fatty Acids | 2 | 2012 | 415 | 0.250 |
Why?
| Physical Conditioning, Animal | 2 | 2006 | 230 | 0.250 |
Why?
| Drug Synergism | 6 | 2003 | 359 | 0.240 |
Why?
| Transcription Factors | 5 | 2004 | 1632 | 0.240 |
Why?
| Transferases | 4 | 1997 | 33 | 0.240 |
Why?
| In Vitro Techniques | 15 | 2003 | 1044 | 0.240 |
Why?
| Adaptor Proteins, Vesicular Transport | 3 | 2001 | 43 | 0.240 |
Why?
| Cell Division | 5 | 2009 | 779 | 0.230 |
Why?
| Diet, Reducing | 1 | 2005 | 84 | 0.230 |
Why?
| Diabetes, Gestational | 2 | 2006 | 308 | 0.230 |
Why?
| Diabetes Complications | 2 | 2019 | 224 | 0.230 |
Why?
| Cardiovascular Physiological Phenomena | 1 | 2004 | 44 | 0.230 |
Why?
| Protein Subunits | 4 | 2008 | 231 | 0.230 |
Why?
| Fetal Blood | 1 | 2006 | 316 | 0.230 |
Why?
| CCAAT-Enhancer-Binding Proteins | 1 | 2004 | 37 | 0.230 |
Why?
| Cell Line | 12 | 2008 | 2737 | 0.220 |
Why?
| Protein Kinase C | 3 | 1996 | 253 | 0.220 |
Why?
| ras Proteins | 2 | 2009 | 145 | 0.210 |
Why?
| Lysophospholipids | 2 | 2001 | 68 | 0.210 |
Why?
| Garlic | 1 | 2003 | 4 | 0.210 |
Why?
| Sulfinic Acids | 1 | 2003 | 8 | 0.210 |
Why?
| Up-Regulation | 1 | 2006 | 828 | 0.200 |
Why?
| Cell Nucleus | 3 | 1995 | 579 | 0.200 |
Why?
| Metabolic Syndrome | 3 | 2013 | 340 | 0.200 |
Why?
| Breast Neoplasms | 3 | 2003 | 2150 | 0.190 |
Why?
| Sodium-Potassium-Exchanging ATPase | 2 | 1992 | 51 | 0.190 |
Why?
| Caloric Restriction | 2 | 2012 | 108 | 0.180 |
Why?
| Aged | 8 | 2025 | 22090 | 0.180 |
Why?
| Plant Extracts | 1 | 2003 | 179 | 0.180 |
Why?
| Cell Cycle | 2 | 2001 | 581 | 0.180 |
Why?
| Growth Substances | 2 | 1998 | 151 | 0.170 |
Why?
| Angiotensin II | 1 | 2000 | 93 | 0.170 |
Why?
| Nitrendipine | 7 | 1993 | 13 | 0.170 |
Why?
| Fetal Diseases | 1 | 2001 | 156 | 0.170 |
Why?
| Weight Loss | 1 | 2005 | 724 | 0.160 |
Why?
| Oxidative Stress | 1 | 2006 | 1192 | 0.160 |
Why?
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 1996 | 42 | 0.160 |
Why?
| Cattle | 6 | 2007 | 963 | 0.160 |
Why?
| Gene Expression Regulation | 3 | 2012 | 2509 | 0.160 |
Why?
| Deoxy Sugars | 2 | 1989 | 2 | 0.160 |
Why?
| Drug Prescriptions | 1 | 2021 | 251 | 0.150 |
Why?
| Insulin Infusion Systems | 2 | 2012 | 362 | 0.150 |
Why?
| Receptor, IGF Type 1 | 1 | 1998 | 66 | 0.150 |
Why?
| GTP-Binding Proteins | 1 | 1999 | 155 | 0.150 |
Why?
| Aging | 5 | 1992 | 1772 | 0.150 |
Why?
| Serine | 2 | 2008 | 136 | 0.150 |
Why?
| Cations | 1 | 1998 | 79 | 0.140 |
Why?
| Fellowships and Scholarships | 1 | 2021 | 275 | 0.140 |
Why?
| Receptors, Somatostatin | 11 | 1986 | 24 | 0.140 |
Why?
| Blood Glucose Self-Monitoring | 2 | 2025 | 601 | 0.140 |
Why?
| Pilot Projects | 2 | 2014 | 1567 | 0.140 |
Why?
| Mitogen-Activated Protein Kinases | 3 | 2003 | 313 | 0.140 |
Why?
| Protein Tyrosine Phosphatases | 3 | 1996 | 168 | 0.140 |
Why?
| Young Adult | 6 | 2020 | 12389 | 0.140 |
Why?
| Models, Organizational | 1 | 2018 | 145 | 0.140 |
Why?
| Time Factors | 7 | 2006 | 6518 | 0.140 |
Why?
| Oncogene Protein v-akt | 2 | 2008 | 25 | 0.130 |
Why?
| Life Style | 1 | 2019 | 460 | 0.130 |
Why?
| NF-kappa B | 1 | 2000 | 652 | 0.130 |
Why?
| Fibroblasts | 6 | 2001 | 942 | 0.130 |
Why?
| Exocytosis | 5 | 1988 | 86 | 0.130 |
Why?
| Retrospective Studies | 4 | 2016 | 14571 | 0.130 |
Why?
| Quality of Health Care | 1 | 2021 | 608 | 0.130 |
Why?
| Hypertension | 3 | 2019 | 1243 | 0.130 |
Why?
| 1-Methyl-3-isobutylxanthine | 6 | 1986 | 22 | 0.130 |
Why?
| Potassium | 7 | 1992 | 138 | 0.130 |
Why?
| Recombinant Proteins | 5 | 2001 | 1284 | 0.130 |
Why?
| Swine, Miniature | 2 | 2013 | 79 | 0.120 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 940 | 0.120 |
Why?
| Calcium-Transporting ATPases | 2 | 1993 | 35 | 0.120 |
Why?
| Mitogen-Activated Protein Kinase 3 | 2 | 2006 | 148 | 0.120 |
Why?
| Mice, Obese | 2 | 2009 | 57 | 0.120 |
Why?
| Somatomedins | 5 | 1981 | 28 | 0.120 |
Why?
| Cardiovascular Agents | 1 | 2016 | 152 | 0.120 |
Why?
| Glycogen Synthase | 2 | 1991 | 7 | 0.120 |
Why?
| Placenta Growth Factor | 2 | 2005 | 24 | 0.120 |
Why?
| Rats, Sprague-Dawley | 5 | 2006 | 2246 | 0.120 |
Why?
| United States | 5 | 2021 | 13941 | 0.110 |
Why?
| Glucose Transporter Type 4 | 3 | 2003 | 39 | 0.110 |
Why?
| Rats, Zucker | 2 | 2007 | 30 | 0.110 |
Why?
| Treatment Outcome | 3 | 2018 | 10227 | 0.110 |
Why?
| Thinness | 2 | 2012 | 90 | 0.110 |
Why?
| Fatty Acid Synthases | 2 | 2006 | 24 | 0.110 |
Why?
| Inulin | 1 | 1993 | 7 | 0.110 |
Why?
| Point-of-Care Systems | 1 | 2015 | 150 | 0.110 |
Why?
| Monitoring, Physiologic | 1 | 2015 | 268 | 0.110 |
Why?
| Glucose Tolerance Test | 3 | 2009 | 356 | 0.110 |
Why?
| ras Guanine Nucleotide Exchange Factors | 5 | 1996 | 8 | 0.100 |
Why?
| Education, Medical | 1 | 1996 | 245 | 0.100 |
Why?
| GRB2 Adaptor Protein | 5 | 2001 | 13 | 0.100 |
Why?
| Guanosine Diphosphate | 4 | 1997 | 20 | 0.100 |
Why?
| Mice, Transgenic | 4 | 2007 | 2079 | 0.100 |
Why?
| Referral and Consultation | 1 | 2018 | 732 | 0.100 |
Why?
| Insulin Antagonists | 2 | 2008 | 8 | 0.100 |
Why?
| Guanine Nucleotide Exchange Factors | 5 | 1996 | 63 | 0.100 |
Why?
| Cricetinae | 3 | 2001 | 275 | 0.100 |
Why?
| Injections, Subcutaneous | 1 | 2012 | 145 | 0.100 |
Why?
| Models, Biological | 4 | 2007 | 1695 | 0.100 |
Why?
| Parenteral Nutrition | 1 | 2013 | 108 | 0.100 |
Why?
| Prognosis | 1 | 2020 | 3788 | 0.090 |
Why?
| Phospholipases A | 1 | 1991 | 99 | 0.090 |
Why?
| ras GTPase-Activating Proteins | 3 | 1996 | 15 | 0.090 |
Why?
| ErbB Receptors | 4 | 1996 | 604 | 0.090 |
Why?
| Transcription, Genetic | 3 | 2012 | 1404 | 0.090 |
Why?
| Flavonoids | 2 | 2004 | 77 | 0.090 |
Why?
| PPAR gamma | 1 | 2012 | 182 | 0.090 |
Why?
| Renal Insufficiency | 1 | 2013 | 148 | 0.090 |
Why?
| GTPase-Activating Proteins | 3 | 1996 | 81 | 0.090 |
Why?
| Isoenzymes | 1 | 1991 | 304 | 0.090 |
Why?
| Chromones | 2 | 2004 | 45 | 0.090 |
Why?
| Membrane Proteins | 2 | 1996 | 1109 | 0.090 |
Why?
| Mice, Inbred C57BL | 4 | 2009 | 5285 | 0.090 |
Why?
| Health Services Accessibility | 1 | 2018 | 897 | 0.090 |
Why?
| RNA | 2 | 2009 | 883 | 0.090 |
Why?
| Oncogene Protein p21(ras) | 3 | 1994 | 16 | 0.090 |
Why?
| Luciferases | 2 | 2000 | 148 | 0.090 |
Why?
| Energy Metabolism | 3 | 2012 | 836 | 0.090 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 1990 | 69 | 0.090 |
Why?
| Reference Values | 5 | 2002 | 780 | 0.080 |
Why?
| Morpholines | 2 | 2004 | 125 | 0.080 |
Why?
| Ion Channels | 2 | 1988 | 127 | 0.080 |
Why?
| Genes, Reporter | 2 | 2000 | 266 | 0.080 |
Why?
| Genes | 1 | 1990 | 226 | 0.080 |
Why?
| Critical Illness | 1 | 2015 | 736 | 0.080 |
Why?
| Diet | 3 | 2013 | 1204 | 0.080 |
Why?
| Tyrosine | 2 | 2008 | 218 | 0.080 |
Why?
| Telemedicine | 1 | 2018 | 783 | 0.080 |
Why?
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 2008 | 4 | 0.080 |
Why?
| Tumor Cells, Cultured | 2 | 2001 | 930 | 0.080 |
Why?
| Renal Dialysis | 1 | 2013 | 420 | 0.080 |
Why?
| Aorta | 1 | 1991 | 407 | 0.080 |
Why?
| Cyclosporins | 1 | 1988 | 59 | 0.080 |
Why?
| CHO Cells | 2 | 2001 | 150 | 0.080 |
Why?
| Cell Movement | 2 | 2003 | 939 | 0.080 |
Why?
| Lipid Metabolism | 1 | 2012 | 493 | 0.080 |
Why?
| Aged, 80 and over | 2 | 2019 | 7066 | 0.080 |
Why?
| Verapamil | 4 | 1988 | 38 | 0.070 |
Why?
| Patient Readmission | 1 | 2014 | 668 | 0.070 |
Why?
| Biological Transport | 3 | 1998 | 394 | 0.070 |
Why?
| Erectile Dysfunction | 1 | 1988 | 39 | 0.070 |
Why?
| Liver Glycogen | 3 | 1986 | 17 | 0.070 |
Why?
| Gene Knockdown Techniques | 1 | 2008 | 312 | 0.070 |
Why?
| Calcium Channels | 1 | 1988 | 152 | 0.070 |
Why?
| Lovastatin | 3 | 1996 | 27 | 0.070 |
Why?
| Swine | 3 | 2013 | 746 | 0.070 |
Why?
| Mevalonic Acid | 2 | 1997 | 11 | 0.070 |
Why?
| PPAR alpha | 1 | 2007 | 59 | 0.070 |
Why?
| Parathyroid Hormone | 3 | 1993 | 106 | 0.070 |
Why?
| Fenofibrate | 1 | 2007 | 31 | 0.070 |
Why?
| Transcription Factor Pit-1 | 1 | 2007 | 24 | 0.070 |
Why?
| Sodium-Phosphate Cotransporter Proteins | 1 | 2007 | 10 | 0.070 |
Why?
| Patient Discharge | 1 | 2014 | 857 | 0.070 |
Why?
| Farnesol | 2 | 1997 | 6 | 0.070 |
Why?
| Exercise Tolerance | 1 | 2009 | 270 | 0.070 |
Why?
| Nitric Oxide Synthase Type III | 2 | 2013 | 201 | 0.070 |
Why?
| Recombinant Fusion Proteins | 2 | 2001 | 635 | 0.070 |
Why?
| Eating | 1 | 1990 | 367 | 0.070 |
Why?
| Gene Expression | 1 | 2012 | 1462 | 0.070 |
Why?
| Hypoglycemia | 1 | 2011 | 426 | 0.070 |
Why?
| Prostheses and Implants | 1 | 1988 | 138 | 0.070 |
Why?
| Hypolipidemic Agents | 1 | 2007 | 93 | 0.070 |
Why?
| Cell Fusion | 1 | 1986 | 51 | 0.070 |
Why?
| Proto-Oncogene Proteins c-raf | 2 | 1996 | 45 | 0.070 |
Why?
| Bucladesine | 3 | 1992 | 24 | 0.070 |
Why?
| Genetic Therapy | 1 | 2008 | 293 | 0.070 |
Why?
| Prospective Studies | 2 | 2012 | 7079 | 0.070 |
Why?
| Adenosine Triphosphate | 3 | 1993 | 471 | 0.070 |
Why?
| RNA, Small Interfering | 1 | 2008 | 571 | 0.070 |
Why?
| Mice, Knockout | 2 | 2005 | 2765 | 0.060 |
Why?
| Mitogen-Activated Protein Kinase 7 | 1 | 2006 | 21 | 0.060 |
Why?
| Organophosphorus Compounds | 2 | 1997 | 78 | 0.060 |
Why?
| Microscopy, Electron | 4 | 1989 | 417 | 0.060 |
Why?
| Macromolecular Substances | 3 | 1996 | 211 | 0.060 |
Why?
| Coated Pits, Cell-Membrane | 1 | 1985 | 4 | 0.060 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2008 | 380 | 0.060 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2011 | 1363 | 0.060 |
Why?
| Heart | 1 | 2009 | 639 | 0.060 |
Why?
| Src Homology 2 Domain-Containing, Transforming Protein 1 | 3 | 2001 | 12 | 0.060 |
Why?
| Shc Signaling Adaptor Proteins | 3 | 2001 | 12 | 0.060 |
Why?
| Macaca mulatta | 1 | 2006 | 148 | 0.060 |
Why?
| Activating Transcription Factor 1 | 2 | 1995 | 9 | 0.060 |
Why?
| Interleukin-1 | 1 | 1989 | 961 | 0.060 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 2006 | 269 | 0.060 |
Why?
| Body Weight | 6 | 2002 | 932 | 0.060 |
Why?
| Peptides | 2 | 1981 | 911 | 0.060 |
Why?
| Theophylline | 1 | 1985 | 64 | 0.060 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 2005 | 179 | 0.060 |
Why?
| Basal Metabolism | 1 | 2005 | 57 | 0.060 |
Why?
| Hemodynamics | 1 | 2009 | 1084 | 0.060 |
Why?
| Endosomes | 1 | 1985 | 127 | 0.060 |
Why?
| Risk | 1 | 2007 | 856 | 0.060 |
Why?
| Retroviridae Proteins, Oncogenic | 1 | 2003 | 11 | 0.060 |
Why?
| Bacterial Proteins | 1 | 1990 | 826 | 0.060 |
Why?
| Blotting, Northern | 3 | 1995 | 199 | 0.050 |
Why?
| Protein-Tyrosine Kinases | 3 | 1993 | 430 | 0.050 |
Why?
| Colorado | 1 | 2014 | 4396 | 0.050 |
Why?
| Arachidonic Acids | 3 | 1988 | 54 | 0.050 |
Why?
| Phosphorus Radioisotopes | 2 | 1993 | 28 | 0.050 |
Why?
| Pregnancy | 3 | 2006 | 6375 | 0.050 |
Why?
| Breast | 1 | 2003 | 153 | 0.050 |
Why?
| Energy Intake | 2 | 2005 | 455 | 0.050 |
Why?
| Proto-Oncogene Proteins | 2 | 1996 | 634 | 0.050 |
Why?
| Hypothyroidism | 2 | 1980 | 71 | 0.050 |
Why?
| Placental Hormones | 1 | 2002 | 4 | 0.050 |
Why?
| Streptozocin | 2 | 1992 | 16 | 0.050 |
Why?
| Cyclin D | 1 | 2001 | 8 | 0.050 |
Why?
| Disease Models, Animal | 4 | 2013 | 3955 | 0.050 |
Why?
| Cyclin E | 1 | 2001 | 23 | 0.050 |
Why?
| Receptors, Progesterone | 1 | 2003 | 345 | 0.050 |
Why?
| Cell Differentiation | 2 | 2001 | 1901 | 0.050 |
Why?
| Carrier Proteins | 3 | 1980 | 732 | 0.050 |
Why?
| Cyclins | 1 | 2001 | 85 | 0.050 |
Why?
| Protein Structure, Tertiary | 1 | 2003 | 836 | 0.050 |
Why?
| Fetal Weight | 1 | 2001 | 56 | 0.050 |
Why?
| Starvation | 1 | 1981 | 22 | 0.050 |
Why?
| Colforsin | 3 | 1991 | 50 | 0.050 |
Why?
| Calmodulin | 3 | 1986 | 75 | 0.040 |
Why?
| Transcriptional Activation | 2 | 2000 | 356 | 0.040 |
Why?
| Nitric Oxide Synthase | 1 | 2001 | 232 | 0.040 |
Why?
| Receptors, Estrogen | 1 | 2003 | 429 | 0.040 |
Why?
| Serum Response Factor | 1 | 2000 | 31 | 0.040 |
Why?
| Infusions, Intravenous | 1 | 2001 | 385 | 0.040 |
Why?
| Glucosamine | 1 | 2000 | 13 | 0.040 |
Why?
| Cyclin-Dependent Kinases | 1 | 2001 | 130 | 0.040 |
Why?
| Maternal-Fetal Exchange | 1 | 2001 | 161 | 0.040 |
Why?
| Response Elements | 1 | 2000 | 89 | 0.040 |
Why?
| Lysosomes | 1 | 1981 | 136 | 0.040 |
Why?
| Adenoviridae | 1 | 2001 | 190 | 0.040 |
Why?
| Glycation End Products, Advanced | 1 | 2000 | 72 | 0.040 |
Why?
| Hypopituitarism | 1 | 1980 | 15 | 0.040 |
Why?
| Son of Sevenless Proteins | 2 | 1996 | 4 | 0.040 |
Why?
| Leptin | 1 | 2001 | 218 | 0.040 |
Why?
| DNA Replication | 1 | 2001 | 225 | 0.040 |
Why?
| Fura-2 | 2 | 1991 | 19 | 0.040 |
Why?
| Disease Progression | 1 | 2007 | 2613 | 0.040 |
Why?
| Mice, Mutant Strains | 1 | 2000 | 292 | 0.040 |
Why?
| Arachidonic Acid | 3 | 1988 | 114 | 0.040 |
Why?
| Receptors, Cytoplasmic and Nuclear | 1 | 2001 | 215 | 0.040 |
Why?
| Muscle Denervation | 1 | 1999 | 10 | 0.040 |
Why?
| Endocrinologists | 1 | 2019 | 12 | 0.040 |
Why?
| Aurothioglucose | 1 | 1999 | 7 | 0.040 |
Why?
| Clenbuterol | 1 | 1999 | 4 | 0.040 |
Why?
| rab3 GTP-Binding Proteins | 1 | 1999 | 4 | 0.040 |
Why?
| rab4 GTP-Binding Proteins | 1 | 1999 | 9 | 0.040 |
Why?
| Body Composition | 3 | 2009 | 657 | 0.040 |
Why?
| Ionomycin | 2 | 1989 | 24 | 0.040 |
Why?
| Dogs | 1 | 2000 | 366 | 0.040 |
Why?
| Fatty Acids, Nonesterified | 3 | 2009 | 159 | 0.040 |
Why?
| Vascular Endothelial Growth Factors | 1 | 1998 | 65 | 0.040 |
Why?
| Endothelial Growth Factors | 1 | 1998 | 51 | 0.040 |
Why?
| Sheep | 1 | 2001 | 829 | 0.040 |
Why?
| Lymphokines | 1 | 1998 | 115 | 0.040 |
Why?
| Hyperlipidemias | 1 | 2019 | 126 | 0.040 |
Why?
| Diabetic Neuropathies | 1 | 2019 | 90 | 0.040 |
Why?
| Ethanol | 1 | 1983 | 585 | 0.040 |
Why?
| Protein Phosphatase 2 | 2 | 1995 | 38 | 0.040 |
Why?
| Binding Sites | 2 | 1996 | 1241 | 0.040 |
Why?
| Protein Processing, Post-Translational | 1 | 2000 | 450 | 0.040 |
Why?
| Prosencephalon | 2 | 1994 | 45 | 0.040 |
Why?
| Half-Life | 1 | 1997 | 144 | 0.040 |
Why?
| Magnesium | 1 | 1998 | 151 | 0.030 |
Why?
| Rats, Wistar | 1 | 1998 | 398 | 0.030 |
Why?
| Dinitrophenols | 3 | 1982 | 8 | 0.030 |
Why?
| Growth Hormone-Releasing Hormone | 2 | 1988 | 24 | 0.030 |
Why?
| Physician's Role | 1 | 2019 | 203 | 0.030 |
Why?
| Diabetic Retinopathy | 1 | 2019 | 171 | 0.030 |
Why?
| Phenytoin | 1 | 1977 | 17 | 0.030 |
Why?
| Fetus | 1 | 2001 | 760 | 0.030 |
Why?
| Accidental Falls | 1 | 2019 | 168 | 0.030 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 1996 | 7 | 0.030 |
Why?
| Immunosorbent Techniques | 1 | 1996 | 19 | 0.030 |
Why?
| Body Mass Index | 1 | 2005 | 2266 | 0.030 |
Why?
| Second Messenger Systems | 1 | 1996 | 32 | 0.030 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 1996 | 21 | 0.030 |
Why?
| Protein Phosphatase 1 | 2 | 1993 | 33 | 0.030 |
Why?
| Oxygen Consumption | 2 | 2009 | 675 | 0.030 |
Why?
| Prediabetic State | 1 | 2019 | 245 | 0.030 |
Why?
| Mitogen-Activated Protein Kinase Kinases | 1 | 1996 | 129 | 0.030 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 1998 | 501 | 0.030 |
Why?
| Nuclear Proteins | 1 | 2000 | 660 | 0.030 |
Why?
| Neurons | 2 | 1994 | 1456 | 0.030 |
Why?
| Rats, Inbred F344 | 2 | 1986 | 251 | 0.030 |
Why?
| Genes, Immediate-Early | 1 | 1995 | 18 | 0.030 |
Why?
| Diabetic Nephropathies | 1 | 2019 | 278 | 0.030 |
Why?
| Immunoblotting | 1 | 1996 | 300 | 0.030 |
Why?
| Infant, Newborn | 1 | 2006 | 5739 | 0.030 |
Why?
| Off-Label Use | 1 | 2015 | 51 | 0.030 |
Why?
| Immediate-Early Proteins | 1 | 1995 | 51 | 0.030 |
Why?
| Research Support as Topic | 1 | 1996 | 113 | 0.030 |
Why?
| Disease Management | 1 | 2019 | 593 | 0.030 |
Why?
| Phenotype | 1 | 2003 | 3058 | 0.030 |
Why?
| Glycogen | 1 | 1995 | 55 | 0.030 |
Why?
| Trypsin | 2 | 1993 | 74 | 0.030 |
Why?
| Neoplasms | 1 | 2009 | 2476 | 0.030 |
Why?
| Peptide Mapping | 1 | 1994 | 61 | 0.030 |
Why?
| Sequence Deletion | 1 | 1995 | 179 | 0.030 |
Why?
| Proto-Oncogene Proteins pp60(c-src) | 1 | 1994 | 12 | 0.030 |
Why?
| DNA | 2 | 1998 | 1392 | 0.030 |
Why?
| ras-GRF1 | 1 | 1993 | 2 | 0.030 |
Why?
| Receptor, ErbB-2 | 1 | 1996 | 336 | 0.030 |
Why?
| Health Services Needs and Demand | 1 | 2015 | 263 | 0.030 |
Why?
| Chloroquine | 2 | 1986 | 52 | 0.030 |
Why?
| Intracellular Membranes | 2 | 1985 | 82 | 0.030 |
Why?
| Thapsigargin | 1 | 1993 | 19 | 0.030 |
Why?
| Carbon Radioisotopes | 1 | 1993 | 35 | 0.030 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 1996 | 431 | 0.030 |
Why?
| Thionucleotides | 1 | 1993 | 34 | 0.030 |
Why?
| Mutation | 1 | 2004 | 3700 | 0.030 |
Why?
| Terpenes | 1 | 1993 | 21 | 0.030 |
Why?
| Renal Insufficiency, Chronic | 1 | 2019 | 566 | 0.030 |
Why?
| Research | 1 | 1996 | 410 | 0.030 |
Why?
| Phenols | 1 | 1993 | 97 | 0.030 |
Why?
| Mutagenesis, Site-Directed | 1 | 1993 | 358 | 0.030 |
Why?
| Amino Acid Sequence | 1 | 1996 | 2041 | 0.030 |
Why?
| Hormones | 2 | 1984 | 140 | 0.030 |
Why?
| Phosphorylase a | 1 | 1992 | 1 | 0.020 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 1996 | 413 | 0.020 |
Why?
| Consensus | 1 | 2015 | 638 | 0.020 |
Why?
| Blood Pressure | 2 | 2009 | 1735 | 0.020 |
Why?
| Peptide Fragments | 1 | 1996 | 686 | 0.020 |
Why?
| Okadaic Acid | 1 | 1991 | 14 | 0.020 |
Why?
| Ethers, Cyclic | 1 | 1991 | 7 | 0.020 |
Why?
| Vanadates | 1 | 1991 | 14 | 0.020 |
Why?
| Mesocricetus | 1 | 1991 | 37 | 0.020 |
Why?
| Glucose Clamp Technique | 1 | 2012 | 195 | 0.020 |
Why?
| Phospholipases A2 | 1 | 1991 | 79 | 0.020 |
Why?
| Cadaverine | 2 | 1982 | 2 | 0.020 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 1992 | 150 | 0.020 |
Why?
| Densitometry | 1 | 1991 | 33 | 0.020 |
Why?
| Calorimetry | 1 | 2012 | 67 | 0.020 |
Why?
| Cell Line, Transformed | 1 | 1991 | 140 | 0.020 |
Why?
| Wheat Germ Agglutinins | 1 | 1991 | 3 | 0.020 |
Why?
| Dietary Proteins | 1 | 2012 | 128 | 0.020 |
Why?
| Mass Screening | 1 | 2019 | 1159 | 0.020 |
Why?
| Arteries | 1 | 2013 | 267 | 0.020 |
Why?
| Sodium | 1 | 1992 | 205 | 0.020 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 1991 | 323 | 0.020 |
Why?
| Sodium Fluoride | 2 | 1981 | 15 | 0.020 |
Why?
| Membrane Potentials | 1 | 1991 | 260 | 0.020 |
Why?
| Deoxyribonucleases, Type II Site-Specific | 1 | 1990 | 15 | 0.020 |
Why?
| Food | 1 | 1992 | 155 | 0.020 |
Why?
| DNA Probes | 1 | 1990 | 61 | 0.020 |
Why?
| Japan | 1 | 1990 | 98 | 0.020 |
Why?
| Secretory Rate | 2 | 1987 | 18 | 0.020 |
Why?
| Homozygote | 1 | 1990 | 193 | 0.020 |
Why?
| Sphingosine | 1 | 1989 | 36 | 0.020 |
Why?
| Vasodilation | 1 | 2013 | 479 | 0.020 |
Why?
| Nonsuppressible Insulin-Like Activity | 2 | 1979 | 2 | 0.020 |
Why?
| Body Fat Distribution | 1 | 2009 | 49 | 0.020 |
Why?
| Polymerase Chain Reaction | 2 | 2007 | 1021 | 0.020 |
Why?
| Plethysmography | 1 | 2009 | 109 | 0.020 |
Why?
| Trifluoperazine | 2 | 1987 | 4 | 0.020 |
Why?
| Hypertrophy, Left Ventricular | 1 | 2009 | 127 | 0.020 |
Why?
| Freeze Fracturing | 1 | 1988 | 5 | 0.020 |
Why?
| Cross-Sectional Studies | 2 | 2009 | 5070 | 0.020 |
Why?
| Hydrostatic Pressure | 1 | 1988 | 18 | 0.020 |
Why?
| Oxidation-Reduction | 1 | 2012 | 1002 | 0.020 |
Why?
| Puberty | 1 | 2009 | 143 | 0.020 |
Why?
| Freezing | 1 | 1988 | 86 | 0.020 |
Why?
| Ethers | 1 | 1987 | 16 | 0.020 |
Why?
| Blood Flow Velocity | 1 | 2009 | 411 | 0.020 |
Why?
| Cholesterol, LDL | 1 | 2009 | 361 | 0.020 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 421 | 0.020 |
Why?
| Egtazic Acid | 1 | 1987 | 41 | 0.020 |
Why?
| Benzofurans | 1 | 1987 | 19 | 0.020 |
Why?
| C-Reactive Protein | 1 | 2009 | 397 | 0.020 |
Why?
| Linear Models | 1 | 2009 | 816 | 0.020 |
Why?
| Spectrometry, Fluorescence | 1 | 1987 | 170 | 0.020 |
Why?
| Digitonin | 1 | 1986 | 5 | 0.020 |
Why?
| Echocardiography | 1 | 2009 | 627 | 0.020 |
Why?
| Culture Techniques | 1 | 1986 | 81 | 0.020 |
Why?
| Exercise Test | 1 | 2009 | 615 | 0.020 |
Why?
| Glyceraldehyde | 1 | 1985 | 2 | 0.020 |
Why?
| DNA Primers | 1 | 2007 | 510 | 0.020 |
Why?
| Adolescent | 4 | 2009 | 20302 | 0.020 |
Why?
| Pronase | 1 | 1985 | 5 | 0.020 |
Why?
| Cell Membrane Permeability | 1 | 1986 | 80 | 0.020 |
Why?
| Sonication | 1 | 1985 | 13 | 0.020 |
Why?
| Heart Failure | 1 | 2019 | 2158 | 0.020 |
Why?
| Lipids | 1 | 2009 | 624 | 0.020 |
Why?
| Feedback | 1 | 1986 | 159 | 0.020 |
Why?
| Fluorescent Dyes | 1 | 1987 | 313 | 0.020 |
Why?
| Urea | 1 | 1985 | 75 | 0.020 |
Why?
| Interleukin-6 | 1 | 2009 | 718 | 0.020 |
Why?
| Stimulation, Chemical | 1 | 1985 | 62 | 0.020 |
Why?
| Golgi Apparatus | 1 | 1985 | 98 | 0.020 |
Why?
| Peptide Hydrolases | 1 | 1986 | 106 | 0.020 |
Why?
| Heart Rate | 1 | 2009 | 808 | 0.010 |
Why?
| Binding, Competitive | 1 | 1985 | 199 | 0.010 |
Why?
| Tissue Distribution | 1 | 1985 | 291 | 0.010 |
Why?
| Biopsy | 1 | 1988 | 1086 | 0.010 |
Why?
| Homeostasis | 1 | 1988 | 605 | 0.010 |
Why?
| Organoids | 1 | 1986 | 105 | 0.010 |
Why?
| Gold | 1 | 1985 | 118 | 0.010 |
Why?
| Motor Activity | 1 | 2009 | 669 | 0.010 |
Why?
| Cardiovascular Diseases | 1 | 2016 | 2024 | 0.010 |
Why?
| Chick Embryo | 2 | 1994 | 130 | 0.010 |
Why?
| Thyroxine | 2 | 1981 | 62 | 0.010 |
Why?
| Perfusion | 2 | 1981 | 188 | 0.010 |
Why?
| Endocytosis | 1 | 1984 | 161 | 0.010 |
Why?
| 2,4-Dinitrophenol | 1 | 1982 | 8 | 0.010 |
Why?
| Cycloheximide | 1 | 1982 | 55 | 0.010 |
Why?
| Colchicine | 1 | 1982 | 25 | 0.010 |
Why?
| Biological Transport, Active | 1 | 1982 | 72 | 0.010 |
Why?
| Ribosomal Protein S6 Kinases | 1 | 2002 | 21 | 0.010 |
Why?
| Deuterium | 1 | 1982 | 86 | 0.010 |
Why?
| Case-Control Studies | 1 | 2009 | 3342 | 0.010 |
Why?
| Receptors, Somatomedin | 1 | 1981 | 4 | 0.010 |
Why?
| Nutrition Disorders | 1 | 1981 | 24 | 0.010 |
Why?
| Radioisotopes | 1 | 1981 | 31 | 0.010 |
Why?
| Purine Nucleotides | 1 | 1981 | 12 | 0.010 |
Why?
| Intracellular Fluid | 1 | 1981 | 27 | 0.010 |
Why?
| Biotransformation | 1 | 1981 | 47 | 0.010 |
Why?
| Adenosine Diphosphate | 1 | 1980 | 78 | 0.010 |
Why?
| Adenosine Monophosphate | 1 | 1980 | 62 | 0.010 |
Why?
| Hydrogen-Ion Concentration | 1 | 1981 | 538 | 0.010 |
Why?
| Statistics as Topic | 1 | 1980 | 304 | 0.010 |
Why?
| Follow-Up Studies | 1 | 1988 | 4915 | 0.010 |
Why?
| Growth Disorders | 1 | 1979 | 80 | 0.010 |
Why?
| Inflammation | 1 | 2009 | 2668 | 0.010 |
Why?
| 11-Hydroxycorticosteroids | 1 | 1977 | 1 | 0.010 |
Why?
| Phosphotyrosine | 1 | 1996 | 36 | 0.010 |
Why?
| RNA-Directed DNA Polymerase | 1 | 1995 | 34 | 0.010 |
Why?
| Child | 2 | 2009 | 20806 | 0.010 |
Why?
| Kidney Failure, Chronic | 1 | 1981 | 535 | 0.010 |
Why?
| Genes, fos | 1 | 1995 | 33 | 0.010 |
Why?
| Structure-Activity Relationship | 1 | 1996 | 531 | 0.010 |
Why?
| Neurites | 1 | 1994 | 46 | 0.010 |
Why?
| Microinjections | 1 | 1994 | 76 | 0.010 |
Why?
| Protein Binding | 1 | 1980 | 2106 | 0.010 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 1994 | 173 | 0.010 |
Why?
| Antibodies | 1 | 1994 | 391 | 0.010 |
Why?
| Base Sequence | 1 | 1995 | 2135 | 0.010 |
Why?
| Cell Survival | 1 | 1994 | 1077 | 0.010 |
Why?
| Molecular Sequence Data | 1 | 1995 | 2819 | 0.010 |
Why?
| Hydroxymercuribenzoates | 1 | 1987 | 1 | 0.000 |
Why?
| Dantrolene | 1 | 1987 | 5 | 0.000 |
Why?
| Oleic Acids | 1 | 1987 | 10 | 0.000 |
Why?
| Lipoxygenase Inhibitors | 1 | 1987 | 35 | 0.000 |
Why?
| Oleic Acid | 1 | 1987 | 39 | 0.000 |
Why?
| Child, Preschool | 1 | 1980 | 10451 | 0.000 |
Why?
| Membrane Fluidity | 1 | 1984 | 11 | 0.000 |
Why?
| Diterpenes | 1 | 1984 | 32 | 0.000 |
Why?
| Glucagon | 1 | 1984 | 105 | 0.000 |
Why?
| Membrane Lipids | 1 | 1984 | 91 | 0.000 |
Why?
| Adenine Nucleotides | 1 | 1982 | 22 | 0.000 |
Why?
| Phospholipids | 1 | 1984 | 209 | 0.000 |
Why?
| Adenosine Triphosphatases | 1 | 1982 | 161 | 0.000 |
Why?
| Nephrectomy | 1 | 1981 | 159 | 0.000 |
Why?
| Propylthiouracil | 1 | 1979 | 3 | 0.000 |
Why?
| Hypophysectomy | 1 | 1979 | 15 | 0.000 |
Why?
| Puromycin | 1 | 1979 | 10 | 0.000 |
Why?
| Radioligand Assay | 1 | 1979 | 46 | 0.000 |
Why?
| Kidney | 1 | 1981 | 1308 | 0.000 |
Why?
|
|
Draznin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|